Wednesday, September 20, 2017

MICROSMETICS: Exploration of microbial biodiversity for the discovery and development of novel cosmeceutical agents
IP: University of Athens
Financing Institution: European Union
Period: 2014-2016

Drugs4Rare: Identifying opportunities for drug repositioning in rare diseases
IP: Barcelona Scientific Park
Financing Institution: Instituto de Salud Carlos III (FIS)
Period: 2012-2013

The chemical space of biological systems: coverage, completeness, mode of action, and evolutionary implications
IP: Jordi Mestres
Financing Institution: Spanish Ministry of Education and Science
Period: 2012-2014.

MeDALL: Mechanisms of the Development of Allergy
IP: INSERM (France) and CREAL
Role in project: Contributor
Financing Institution: European Union
Period: 2011-2014

Open PHACTS: an open, integrated, and sustainable chemistry, biology, and pharmacology knowledge resource for drug discovery
IP: Universit├Ąt Wien (Austria)
Financing Institution: European Union
Period: 2011-2013.

New structure-based methodologies for the identification of ligands with designed polypharmacology
IP: Jordi Mestres
Financing Institution: Catalan Government
Period: 2011-2013

ARITMO: Arrhythmogenic potential of drugs
IP: Erasmus University Medical Center (The Netherlands)
Role in project: Contributor
Financing Institution: European Union
Period: 2010-2012

Support to academic research projects
IP: Jordi Mestres
Financing institution: Spanish Ministry of Education and Science
Period: 2010-2012

eTOX: Integration of bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
IP: University Pompeu Fabra
Financing institution: European Union
Period: 2009-2013

Development of new integrative methodologies for the identification of new therapeutic uses for old drugs
IP: Jordi Mestres
Financing Institution: Spanish Ministry of Education and Science
Period: 2009-2011

ALERT: Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge
IP: Erasmus University Medical Center (The Netherlands)
Financing institution: European Union
Period: 2008-2010

CancerGrid: Grid aided computer system for rapid anti-cancer drug design
IP: AMRI (Hungary)
Financing Institution: European Union
Period: 2007-2009

Development of common technological platforms to assist in progressing new preclinical candidates in priority therapeutic areas
IP: Genius Pharma (CENIT project)
Financing institution: Spanish Ministerio de Industry
Period: 2006-2009

Development of new knowledge-based approaches to refine protein models and their application to ligand design
IP: Jordi Mestres
Financing institution: Spanish Ministry of Education and Science
Period: 2005-2008

INFOBIOMED: Structuring biomedical informatics for individualised healthcare
IP: University Pompeu Fabra
Financing institution: European Union
Period: 2004-2007

Development of novel biochemoinformatics tools for the integration of chemical and biological data
IP: Jordi Mestres
Financing institution: University Pompeu Fabra
Period: 2004-2006

Development of a chemogenomics platform for designing bioactive ligands directed to entire protein families
IP: Jordi Mestres
Financing institution: Instituto de Salud Carlos III (FIS)
Period: 2003-2005